AR and neoplasm: Given these findings, the enrichment of AR-independent pathways supports investigating bioactive compounds of rosemary as potential multi-targeted therapies to inhibit tumor growth and survival in AR-negative prostate cancer, where conventional hormonal treatments are ineffective.